Tag: irving kirsch

New Data Reveal the Full Extent of STAR*D Failure

20
The initial study, which has been used to promote antidepressants, employed outcome switching to hide poor results.

Researchers: ā€œAntidepressants Should Not be Used for Adults with Major Depressive...

7
A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.

Depression, Antidepressants, and Expectancy

7
This study reinforces a large body of evidence suggesting that an individualā€™s expectancies for improvement significantly contribute to their actual improvement. The importance of expectancies is worth paying attention to now as more clients, clinicians, and researchers are endorsing a reductionist view of psychological disorders -- i.e., that psychological disorders are fundamentally brain disorders.

Lancet Editorial Points to “Trouble with Psychiatry Trials”

4
While clinical trials make up the ā€œbedrock of evidence-based medicineā€ in other specialties, psychiatry faces a number of both ethical and scientific problems related to its use of randomized control trials. According to a new editorial in The Lancet Psychiatry, the field of psychiatry research has particular problems with ethical issues in recruitment, inaccurate classification systems, and controversial placebo comparisons, and then, once the studies are finished, it often remains unclear what the ā€œoutcomes actually mean for peopleā€™s lives.ā€

The American Psychiatric Association’s Response to 60 Minutes: Where is the...

The American Psychiatric Association (APA) has posted a response to the 60 minutes segment on Irving Kirsch and the placebo effect in antidepressant research. But is their response based on scientific data?

60 Minutes, The SSRIs, and The Dirty Little Secret

Last night, 60 Minutes presented the work of Irving Kirsch, who has been researching the placebo effect in antidepressants for many years. We discuss.